Miriam Wittmann

Miriam Wittmann

University of Leeds

H-index: 45

Europe-United Kingdom

About Miriam Wittmann

Miriam Wittmann, With an exceptional h-index of 45 and a recent h-index of 29 (since 2020), a distinguished researcher at University of Leeds, specializes in the field of immunology, dermatology, allergy, autoimmunity.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.

Bridging the gaps: management of lichen planus subtypes in a joint dermatology–oral surgery clinic

Predictors of BILAG-based outcomes in patients with SLE: Analysis from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

P31 Trial design to improve inclusion of patients from ethnic minority backgrounds

006 Comparison of alitretinoin vs. psoralen plus ultraviolet A as first-line treatments for chronic severe hand eczema: results from the ALPHA trial

Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus

Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases

IL-17A-driven psoriasis is critically dependent on IL-36 signaling

Miriam Wittmann Information

University

Position

___

Citations(all)

5957

Citations(since 2020)

2704

Cited By

4163

hIndex(all)

45

hIndex(since 2020)

29

i10Index(all)

86

i10Index(since 2020)

66

Email

University Profile Page

Google Scholar

Miriam Wittmann Skills & Research Interests

immunology

dermatology

allergy

autoimmunity

Top articles of Miriam Wittmann

Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.

Health Technology Assessment (Winchester, England)

2024/1

Miriam Wittmann
Miriam Wittmann

H-Index: 27

Bridging the gaps: management of lichen planus subtypes in a joint dermatology–oral surgery clinic

2024/1

Miriam Wittmann
Miriam Wittmann

H-Index: 27

P31 Trial design to improve inclusion of patients from ethnic minority backgrounds

British Journal of Dermatology

2023/6

Jane Nixon
Jane Nixon

H-Index: 32

Miriam Wittmann
Miriam Wittmann

H-Index: 27

006 Comparison of alitretinoin vs. psoralen plus ultraviolet A as first-line treatments for chronic severe hand eczema: results from the ALPHA trial

British Journal of Dermatology

2023/6

Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus

Arthritis & Rheumatology

2023/5

IL-17A-driven psoriasis is critically dependent on IL-36 signaling

Frontiers in Immunology

2023/12/11

Ari Waisman
Ari Waisman

H-Index: 58

Miriam Wittmann
Miriam Wittmann

H-Index: 27

Hand eczema leaves systemic traces

British Journal of Dermatology

2023/5/24

Miriam Wittmann
Miriam Wittmann

H-Index: 27

404 Plaque Psoriasis patients with Psoriatic Arthritis demonstrate a reduced capacity to neutralise neutrophil derived elastase compared to plaque psoriasis patients without …

Journal of Investigative Dermatology

2022/12/1

T helper 2 IL-4/IL-13 dual blockade with dupilumab is linked to some emergent T helper 17‒type diseases, including seronegative arthritis and enthesitis/enthesopathy, but not …

Journal of Investigative Dermatology

2022/10/1

Toward Cannabinoid Use for Refractory Cutaneous Dermatomyositis

The Journal of investigative dermatology

2022/10

Miriam Wittmann
Miriam Wittmann

H-Index: 27

Emerging concepts of type I interferons in SLE pathogenesis and therapy

2022/10

Miriam Wittmann
Miriam Wittmann

H-Index: 27

Molecular and cellular regulation of psoriatic inflammation

2022/6

OA09 Gene expression analysis reveals distinct ancestry-specific profiles associated with response to rituximab in SLE

Rheumatology

2022/5/1

Applying early intervention strategies to autoimmune skin diseases. Is the window of opportunity preclinical? A dermato-rheumatology perspective

2022/3/1

Miriam Wittmann
Miriam Wittmann

H-Index: 27

Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial

BMJ open

2022/2/1

The immunological impact of IL-1 family cytokines on the epidermal barrier

2021/12/23

Unexpected connections of the IL-23/IL-17 and IL-4/IL-13 cytokine axes in inflammatory arthritis and enthesitis

2021/12/1

Milestones in Personalized Medicine in Pemphigus and Pemphigoid

Precision Medicine in Chronic Inflammation

2021/11/9

Miriam Wittmann
Miriam Wittmann

H-Index: 27

See List of Professors in Miriam Wittmann University(University of Leeds)